Akums Drugs and Pharmaceutical Net Asset Momentum
Akums Drugs and Pharmaceutical net asset momentum. Akums Drugs and Pharmaceutical (AKUMS) recorded a net asset momentum of 8.7% as of March 2026, with net assets of Rs33.31 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Akums Drugs and Pharmaceutical capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Akums Drugs and Pharmaceutical (2022–2026)
Net asset momentum of Akums Drugs and Pharmaceutical from 2022 to 2026. This chart tracks Akums Drugs and Pharmaceutical's year-over-year net asset growth across 5 annual reporting periods from 2022 to 2026. The most recent momentum reading is +8.7%, with net assets of Rs33.31 Billion INR as of March 2026. See Akums Drugs and Pharmaceutical (AKUMS) net assets for net asset value and shareholders' equity analysis.
Akums Drugs and Pharmaceutical Net Asset Momentum by Year (2022–2026)
Akums Drugs and Pharmaceutical net asset momentum by year from 2022 to 2026. The table below shows the complete annual net asset history for Akums Drugs and Pharmaceutical from 2022 to 2026, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see AKUMS company net worth.
| Year | Net Assets (INR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2026 | Rs33.31 Billion | Rs54.47 Billion | Rs21.16 Billion | ▲ +8.7% |
| 2025 | Rs30.64 Billion | Rs41.13 Billion | Rs10.50 Billion | ▲ +325.2% |
| 2024 | Rs7.20 Billion | Rs35.16 Billion | Rs27.96 Billion | ▼ -0.4% |
| 2023 | Rs7.23 Billion | Rs32.67 Billion | Rs25.43 Billion | ▲ +15.7% |
| 2022 | Rs6.25 Billion | Rs30.69 Billion | Rs24.44 Billion | — |